ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome

ClinicalTrials.gov ID: NCT00593736

Public ClinicalTrials.gov record NCT00593736. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 8:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel, Proof of Concept Study to Evaluate the Effectiveness of Ramelteon to Advance the Timing of Sleep in Individuals With Delayed Sleep Phase Syndrome (DSPS)

Study identification

NCT ID
NCT00593736
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Takeda
Industry
Enrollment
132 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Ramelteon Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2007
Primary completion
Apr 30, 2008
Completion
Apr 30, 2008
Last update posted
Feb 27, 2012

2007 – 2008

United States locations

U.S. sites
42
U.S. states
23
U.S. cities
42
Facility City State ZIP Site status
Not listed Birmingham Alabama
Not listed Tucson Arizona
Not listed Hot Springs Arkansas
Not listed Little Rock Arkansas
Not listed Fountain Valley California
Not listed Glendale California
Not listed Los Angeles California
Not listed San Diego California
Not listed Santa Monica California
Not listed Tustin California
Not listed Colorado Springs Colorado
Not listed Hallandale Bch Florida
Not listed Naples Florida
Not listed Pembroke Pines Florida
Not listed South Miami Florida
Not listed Spring Hill Florida
Not listed St. Petersburg Florida
Not listed Winter Park Florida
Not listed Atlanta Georgia
Not listed Gainesville Georgia
Not listed Macon Georgia
Not listed Chicago Illinois
Not listed Danville Indiana
Not listed Overland Park Kansas
Not listed Topeka Kansas
Not listed Crestview Hills Kentucky
Not listed Paducah Kentucky
Not listed Chevy Chase Maryland
Not listed Newton Massachusetts
Not listed Hattiesburg Mississippi
Not listed Lincoln Nebraska
Not listed Las Vegas Nevada
Not listed New York New York
Not listed Raleigh North Carolina
Not listed Salisbury North Carolina
Not listed Cincinnati Ohio
Not listed Dublin Ohio
Not listed Toledo Ohio
Not listed Salem Oregon
Not listed Clarks Summit Pennsylvania
Not listed Columbia South Carolina
Not listed Austin Texas

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00593736, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 27, 2012 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00593736 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →